Expert Answers to Pathologist Questions on New Biomarkers for Precision Therapy in Lung Cance

In this podcast episode, listen to Nathan Pennell, MD, PhD, a medical oncologist, and Laura J. Tafe, MD, a molecular pathologist, as they answer questions from a clinician audience on best practices when testing for actionable mutations in NSCLC.